Washington [US], May 7 (ANI/Sputnik): The European Medicine Agency (EMA) said on Friday that its committee on vaccine safety asked AstraZeneca to provide additional trial data on its COVID-19 drug for an inquiry into cases of a rare autoimmune disorder following vaccination.